David W. Chan

LKS Faculty Of Medicine, 21 Sassoon Road
Hong Kong, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 68 publications

Erratum: SCD1/FADS2 fatty acid desaturases equipoise lipid metabolic activity and redox-driven ferroptosis in ascites-derived ovarian cancer cells: Erratum.

Erratum: SCD1/FADS2 fatty acid desaturases equipoise lipid metabolic activity and redox-driven ferroptosis in ascites-derived ovarian cancer cells: Erratum.

Journal: Theranostics
Published: June 05, 2026

VAMP2/SNAP25 promotes the aggressive progression of head and neck cancer by regulating the fate of multivesicular bodies.

VAMP2/SNAP25 promotes the aggressive progression of head and neck cancer by regulating the fate of multivesicular bodies.

Journal: Cancer biology & medicine
Published: May 13, 2026

Correction to: Autocrine activation of JAK2 by IL-11 promotes platinum drug resistance.

Correction to: Autocrine activation of JAK2 by IL-11 promotes platinum drug resistance.

Journal: Oncogene
Published: May 11, 2026

Retraction Note: Reduced expression of AMPK-β1 during tumor progression enhances the oncogenic capacity of advanced ovarian cancer.

Retraction Note: Reduced expression of AMPK-β1 during tumor progression enhances the oncogenic capacity of advanced ovarian cancer.

Journal: Molecular cancer
Published: March 11, 2026

Retraction Note: miR-137 mediates the functional link between c-Myc and EZH2 that regulates cisplatin resistance in ovarian cancer.

Retraction Note: miR-137 mediates the functional link between c-Myc and EZH2 that regulates cisplatin resistance in ovarian cancer.

Journal: Oncogene
Published: January 16, 2026

Oncogenic Activity and Sorafenib Sensitivity of ARAF p.S214C Mutation in Lung Cancer.

Oncogenic Activity and Sorafenib Sensitivity of ARAF p.S214C Mutation in Lung Cancer.

Journal: Cancers
Published: June 09, 2025

Author Correction: Targeting of lipid metabolism with a metabolic inhibitor cocktail eradicates peritoneal metastases in ovarian cancer cells.

Author Correction: Targeting of lipid metabolism with a metabolic inhibitor cocktail eradicates peritoneal metastases in ovarian cancer cells.

Journal: Communications biology
Published: February 23, 2025

Challenging arterial patterns of renal and testicular arteries in a human cadaver: clinical significance and embryological bases revisited.

Challenging arterial patterns of renal and testicular arteries in a human cadaver: clinical significance and embryological bases revisited.

Journal: Anatomy & cell biology
Published: December 26, 2024

Exosomes: Key Factors in Ovarian Cancer Peritoneal Metastasis and Drug Resistance.

Exosomes: Key Factors in Ovarian Cancer Peritoneal Metastasis and Drug Resistance.

Journal: Biomolecules
Published: August 03, 2024

MOGAT3-mediated DAG accumulation drives acquired resistance to anti-BRAF/anti-EGFR therapy in BRAFV600E-mutant metastatic colorectal cancer.

MOGAT3-mediated DAG accumulation drives acquired resistance to anti-BRAF/anti-EGFR therapy in BRAFV600E-mutant metastatic colorectal cancer.

Journal: The Journal of clinical investigation
Published: April 22, 2024

An increase of serum CA-125 to two times of nadir level strongly predicts the image-identified relapse of serous ovarian cancer.

An increase of serum CA-125 to two times of nadir level strongly predicts the image-identified relapse of serous ovarian cancer.

Journal: Scientific reports
Published: January 04, 2024

Polyunsaturated fatty acids promote M2-like TAM deposition via dampening RhoA-YAP1 signaling in the ovarian cancer microenvironment.

Polyunsaturated fatty acids promote M2-like TAM deposition via dampening RhoA-YAP1 signaling in the ovarian cancer microenvironment.

Journal: Experimental hematology & oncology
Published: October 11, 2023
Showing 1-12 of 68

Last Updated: 09/26/2026